Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joan Ryoo

Therapeutic Radiology Los Angeles, CA Medical Doctor

NPI 1699854596 CMS profile 639365

4950 W Sunset Blvd, Second Floor, Los Angeles, CA 90027

Open in the dashboard

General payments

$572

16 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joan Ryoo of Los Angeles, CA is reported in the CMS Open Payments database as having received $572 across 16 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 61st percentile of Therapeutic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $218 2
2024 General $28 1
2023 General $118 4
2022 General $111 4
2021 General $48 2
2020 General $21 1
2019 General $29 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joan Ryoo
  • Therapeutic Radiology median
  • Middle half of Therapeutic Radiology
  • National median

In program year 2025, general payments to Joan Ryoo were reported at $218. Among 82 Therapeutic Radiology profiles paid that year, the median was $179 and the middle half received between $54 and $602.

Show as a table
Year Joan Ryoo Therapeutic Radiology median Middle half National median
2019 $29 $108 $31–$339 $163
2020 $21 $48 $28–$197 $114
2021 $48 $72 $23–$391 $132
2022 $111 $77 $31–$399 $149
2023 $118 $148 $55–$613 $160
2024 $28 $172 $45–$795 $164
2025 $218 $179 $54–$602 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Siemens Medical Solutions USA, Inc. $218 2 payments
  2. GT Medical Technologies, Inc $78 3 payments
  3. Elekta, Inc. $67 2 payments
  4. Novocure Inc. $55 3 payments
  5. Palette Life Sciences, Inc. $51 1 payment
  6. Boston Scientific Corporation $32 1 payment
  7. VisionRT, Inc. $22 1 payment
  8. Varian Medical Systems, Inc. $21 1 payment
  9. RefleXion Medical, Inc. $17 1 payment
  10. Viewray Technologies Inc $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $572 16 payments
Products named General payments · program years 2019–2025
  1. GammaTile $78 3 payments
  2. ELEKTA MEDICAL LINEAR ACCELERATOR $45 1 payment
  3. Optune Gio $44 2 payments
  4. SPACEOAR VUE $32 1 payment
  5. Eclipse Treatment Planning System for External Beam Radiation Therapy $23 1 payment
  6. ELEKTA UNITY $22 1 payment
  7. REFLEXION MEDICAL RADIOTHERAPY SYSTEM $17 1 payment
  8. Oncology $17 1 payment
  9. Optune $16 1 payment
  10. MRIdian $12 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

111

Median for Radiation Oncology: 65

Drug cost

$2,530

Median for Radiation Oncology: $978

Branded share of claims

34.2%

Median for Radiation Oncology: 7.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ssd Silver Sulfadiazine Brand 17 $671
Hydrocortisone Generic 25 $603
Tamsulosin Hcl Generic 36 $572
Silver Sulfadiazine Generic 12 $470
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 21 $215

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,680 Part D prescribers listed as Radiation Oncology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$13,193

Medicare's payments for the services billed

Medicare patients

20

Average age 69

Services billed

77

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Cancer 75%
High blood pressure 60%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

16 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Therapeutic Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record